|
TBC1D8B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.319200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.409200E-01 |
| Normal-vs-Stage2 |
2.554600E-01 |
| Normal-vs-Stage3 |
3.662600E-01 |
| Normal-vs-Stage4 |
7.662400E-01 |
| Stage1-vs-Stage2 |
6.992800E-01 |
| Stage1-vs-Stage3 |
9.983400E-01 |
| Stage1-vs-Stage4 |
2.641800E-01 |
| Stage2-vs-Stage3 |
7.603200E-01 |
| Stage2-vs-Stage4 |
3.026400E-01 |
| Stage3-vs-Stage4 |
4.440800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.541240E-01 |
| Normal-vs-AfricanAmerican |
1.115150E-01 |
| Normal-vs-Asian |
9.604800E-01 |
| Caucasian-vs-AfricanAmerican |
6.80610000025617E-07 |
| Caucasian-vs-Asian |
5.668600E-01 |
| AfricanAmerican-vs-Asian |
2.890600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.700200E-02 |
| Normal-vs-Female |
6.921000E-01 |
| Male-vs-Female |
4.16810000000156E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.944000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.504240E-01 |
| Normal-vs-Age(61-80Yrs) |
2.657000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.608800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.449200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.727800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.905400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.696000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.986400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.476200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.827780E-01 |
| Normal-vs-Grade 2 |
9.868300E-02 |
| Normal-vs-Grade 3 |
4.429400E-01 |
| Normal-vs-Grade 4 |
9.999000E-01 |
| Grade 1-vs-Grade 2 |
8.201400E-01 |
| Grade 1-vs-Grade 3 |
4.254200E-01 |
| Grade 1-vs-Grade 4 |
1.739190E-01 |
| Grade 2-vs-Grade 3 |
1.383810E-01 |
| Grade 2-vs-Grade 4 |
8.803600E-02 |
| Grade 3-vs-Grade 4 |
4.189600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.524300E-03 |
| Normal-vs-ccB subtype |
8.494600E-01 |
| ccA subtype-vs-ccB subtype |
1.115750E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.836800E-01 |
| Normal-vs-N1 |
6.329200E-01 |
| N0-vs-N1 |
8.586200E-01 |
|
|
